Margeli A P, Skaltsas S D, Spiliopoulou C A, Mykoniatis M G, Theocharis S E
Department of Experimental Pharmacology, University of Athens, Medical School, Greece.
Liver. 1999 Dec;19(6):519-25. doi: 10.1111/j.1478-3231.1999.tb00085.x.
AIMS/BACKGROUND: Hepatic stimulator substance (HSS) is a known hepatic growth factor which appears to be organ-specific but species non-specific. We have recently shown that the administration of HSS enhanced hepatocyte proliferation occurring due to thioacetamide (TAA)-induced liver injury in rats (Theocharis SE, et al., Scand J Gastroenterol 1998; 33: 656-63). In the present study, we examined the activity of the endogenously produced HSS in the liver of TAA administered rats during injury and regeneration.
TAA at a dose of 300 mg/kg of body weight was injected intraperitoneally in male Wistar rats. The animals were sacrificed at 0, 12, 24, 36, 48, 60 and 72 h after TAA administration. The rate of tritiated thymidine incorporation into hepatic DNA, the enzymatic activity of liver thymidine kinase and the assessment of mitotic index in hepatocytes were used to estimate liver regeneration. HSS extract was obtained from the livers of TAA-treated rats, sacrificed at the above mentioned time points. This HSS extract was injected in 34% partially hepatectomized rats, to assess its activity. The ability of the injected HSS extract to increase hepatocellular proliferation over that normally occurring 24 h following 34% partial hepatectomy was used to express the activity of HSS by determining the above mentioned indices of liver regeneration.
The administration of TAA caused severe hepatic injury recognized histopathologically as well as by the increased activities of serum hepatic enzymes aspartate and alanine aminotrasferases. The hepatic injury, which peaked at 24 and 36 h post-TAA treatment (p<0.001), was followed by hepatocyte proliferation, presenting peaks at 48 and 60 h (p<0.001). The activity of the endogenously produced HSS from livers of TAA-treated rats increased at 36 h after TAA administration as well as being highly expressed at 48 and 60 h thus coinciding with the peak of hepatocyte proliferation. At other time points, HSS activity was decreased.
The observed variations of HSS activity in rat liver suggest active participation of this growth factor in hepatocyte replication which follows toxin-induced liver injury as a repair mechanism process.
目的/背景:肝刺激物质(HSS)是一种已知的肝生长因子,似乎具有器官特异性但无物种特异性。我们最近发现,给予HSS可增强大鼠因硫代乙酰胺(TAA)诱导的肝损伤而发生的肝细胞增殖(Theocharis SE等人,《 Scandinavian Journal of Gastroenterology》1998年;33:656 - 63)。在本研究中,我们检测了TAA处理的大鼠在肝损伤和再生过程中内源性产生的HSS在肝脏中的活性。
将剂量为300 mg/kg体重的TAA腹腔注射到雄性Wistar大鼠体内。在给予TAA后的0、12、24、36、48、60和72小时处死动物。用氚标记的胸腺嘧啶核苷掺入肝DNA的速率、肝胸腺嘧啶激酶的酶活性以及肝细胞有丝分裂指数的评估来估计肝再生。从在上述时间点处死的TAA处理大鼠的肝脏中获得HSS提取物。将这种HSS提取物注射到34%部分肝切除的大鼠中,以评估其活性。通过测定上述肝再生指标,用注射的HSS提取物比34%部分肝切除后正常24小时内肝细胞增殖增加的能力来表达HSS的活性。
给予TAA导致严重的肝损伤,这在组织病理学上以及血清肝酶天冬氨酸和丙氨酸转氨酶活性增加方面都得到了证实。肝损伤在TAA处理后24和36小时达到峰值(p<0.001),随后是肝细胞增殖,在48和60小时出现峰值(p<0.001)。TAA处理大鼠肝脏中内源性产生的HSS活性在给予TAA后36小时增加,并在48和60小时高度表达,因此与肝细胞增殖的峰值一致。在其他时间点,HSS活性降低。
在大鼠肝脏中观察到的HSS活性变化表明,这种生长因子积极参与了毒素诱导的肝损伤后作为修复机制过程的肝细胞复制。